Recent progress in the structural modification and pharmacological activities of ligustrazine derivatives
Authors:
- 1 March 2018
- journal article
- review article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 147, 150-162
Abstract
No abstract availableKeywords
Funding Information
- National Key Projects of New Drugs R&D (2009ZX09103-117)
- Shandong Natural Science Foundation
- Science and Technology Development Foundation of Shandong Province (2006GG2202063)
- Key Research and Development Project of Shandong Province (2017CXGC1401)
- Major Project of Science and Technology of Shandong Province (2015ZDJS04001)
This publication has 89 references indexed in Scilit:
- Contact Sensitizers Induce Skin Inflammation via ROS Production and Hyaluronic Acid DegradationPLOS ONE, 2012
- Synthesis and Biological Evaluation of New Ligustrazine Derivatives as Anti-Tumor AgentsMolecules, 2012
- The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammationNature Immunology, 2011
- Pardaxin, an Antimicrobial Peptide, Triggers Caspase-Dependent and ROS-Mediated Apoptosis in HT-1080 CellsMarine Drugs, 2011
- Towards a unifying, systems biology understanding of large-scale cellular death and destruction caused by poorly liganded iron: Parkinson’s, Huntington’s, Alzheimer’s, prions, bactericides, chemical toxicology and others as examplesArchives of Toxicology, 2010
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- Nitrones as therapeuticsFree Radical Biology and Medicine, 2008
- Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid ResistanceAntimicrobial Agents and Chemotherapy, 2008
- Free radicals and antioxidants in normal physiological functions and human diseaseThe International Journal of Biochemistry & Cell Biology, 2007
- Stem cells for the treatment of neurological disordersNature, 2006